http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2016219654-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ece626521aa0302ca2defed56c85a2f8
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-66
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10
filingDate 2016-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5220a04dbe474bbfd93bcc05044478b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_daf1ec25a2963996c3266cc7a432bcc7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7ce586ba27898f54c9b8bb021d49fa2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef94aa02b5f1cd6bee462cd7ced932d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3af00539ac444c5ffbecf8c06492689f
publicationDate 2016-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AU-2016219654-A1
titleOfInvention Crystallization method and bioavailability
abstract CRYSTALLIZATION METHOD AND BIOAVAILABILITY The disclosure relates to preparation, in-vitro and in vivo characterization of novel forms of (1 -hydroxy-2-imidazol- 1-yl-1 -phosphono-ethyl) phosphonic acid, suitable for pharmaceutical compositions in drug delivery systems for humans.
priorityDate 2009-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535486
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68740

Total number of triples: 38.